Skip to main content

Oncology

Treatment with venetoclax plus azacitidine achieved a sustained clinical response in a patient with isolated extramedullary relapse of acute myeloid leukemia after transplantation.

Dabrafenib plus trametinib is superior to standard chemotherapy in untreated pediatric patients with low-grade glioma carrying BRAF V600 mutations.

A review of the latest findings pertaining to endobronchial ultrasound and lung cancer staging, with an aim to equip clinicians with evidence-based recommendations and highlight avenues for further research.

Chemotherapy-induced peripheral neuropathy is a debilitating long-term side effect, with increasing prevalence due to the rising life expectancy of cancer survivors. Its pathophysiology, diagnosis, clinical presentation, and treatment are discussed.

Case-Based Insights: Oncology and Hematology


Refresh your knowledge in Oncology and Hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Log in or register for free

Episode 5: Next-generation sequencing

Emerging biomarkers in thyroid and non-small cell lung cancers

Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. In this podcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint.

This content is intended only for healthcare providers and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company.

Listen now

Treatment with venetoclax plus azacitidine achieved a sustained clinical response in a patient with isolated extramedullary relapse of acute myeloid leukemia after transplantation.

A case series of pediatric patients points to the need for both endoscopy and colonoscopy in those presenting with nonspecific GI symptoms after transplantation for early diagnosis of post-transplant lymphoproliferative disorder.

Intracranial GCTs developed occult extracranial malignancy with negative tumor markers, indicating that tumor marker monitoring may need to be combined with regular follow-up abdominal imaging for early detection.

Current Reviews

Identifying molecular biomarkers is crucial in determining the best targeted treatment options for your patients with advanced thyroid cancer.

Join our expert-led multi-format educational program that explores the continuing discovery of new genomic targets and delivers the latest research in molecular testing and the application of targeted therapies for thyroid cancer.

Start by watching our webcast and short vodcasts.

Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

CME: 1.0 AMA PRA Category 1 Credit(s)™

Knowledge center focusing on improving the individualized management of HR+/HER2- early breast cancer 

CME: 0.75 AMA PRA Category 1 Credit(s)™

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Further Reading

Related topics

Treatment with venetoclax plus azacitidine achieved a sustained clinical response in a patient with isolated extramedullary relapse of acute myeloid leukemia after transplantation.

Read more

Central nervous system radiotoxicity remains a challenge in neuro-oncology. This review explores the role of proton therapy in reducing such toxicities in adult patients receiving CNS-directed radiotherapy.

Read more